Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 603 of 1,261

  1. US 9790271

    Methods for increasing immunoglobulin A levels

    VACCINEX, INC. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  2. US 9790218

    Small molecule activators of calcium-activated chloride channels and methods of use

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  3. US 9790233

    Compositions and methods of modulating 15-PGDH activity

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  4. US 9790272

    Stem cell factor inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  5. US 9790180

    Piperidine derivatives as HDAC1/2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  6. US 9790158

    Substituted tropolone derivatives and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  7. US 9789209

    Activatable membrane-interacting peptides and methods of use

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  8. US 9789205

    Compositions and methods for gene therapy

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  9. US 9783525

    Map kinase modulators and uses thereof

    Northwestern University · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  10. US 9783827

    DNA-binding proteins and uses thereof

    Sangamo Therapeutics, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  11. US 9783855

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  12. US 9783787

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  13. US 9783788

    Porcine pseudorabies virus (PRV)-YF strain and its application

    SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  14. US 9783806

    TMPRSS6 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  15. US 9783596

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  16. US 9783595

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  17. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  18. US 9783590

    Variants of human taste receptor genes

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  19. US 9783550

    Highly potent inhibitors of porcupine

    The Board of Regents of the University of Texas System · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  20. US 9783515

    Radiomitigating pharmaceutical formulations

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  21. US 9783858

    Altered microbiome of chronic pelvic pain

    Northwestern University · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  22. US 9782464

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  23. US 9783572

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  24. US 9782430

    Resorbable oxidized cellulose embolization solution

    Covidien LP · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.